Tag: ubiquitination

PROTACs improve selectivity for targeted proteins

Announcing a new publication for Acta Materia Medica journal.  Proteolysis targeting chimera (PROTAC) technology has emerged as a powerful tool in drug discovery that enables targeted protein degradation through a unique bifunctional approach. This review provides a comprehensive overview of PROTACs with a focus on recent advances in enhancing selectivity and therapeutic potential. We begin […]